Immunohistochemical (IHC) staining of subcutaneous tumors in nude mice revealed that the combined administration of gefitinib and stiripentol significantly reduced Ki67 expression within the tumor tissues (Fig. S7B and C). This evidence concerns the gene MKI67 and neoplasm.